Minster Research Ltd Report issue

For profit Phase 2
Founded: London United Kingdom (1950)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2006
NCT00311662
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

tonabersat (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Headache (Phase 2)

Migraine Disorders (Phase 2)

Migraine with Aura (Phase 2)

Migraine without Aura (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1